Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mogroside for Delayed-Onset Muscle Soreness
NCT07836985Not yet recruiting
- Sponsor
- Guangxi Normal University
- Start
- Sep 2026
- Primary completion
- Nov 2026
01
Overview
Randomised, double-blind trial in delayed onset muscle soreness (DOMS) (2 arms), sponsored by Guangxi Normal University. Primary endpoint: Visual Analog Scale for Muscle Soreness. Planned start Sep 2026; status: not yet recruiting.
02
Conditions
delayed onset muscle soreness (DOMS)
Beyond the preview
Go deeper on NCT07836985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07836985.